BREAKING
Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 1 day ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 1 day ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 1 day ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 1 day ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 1 day ago Abbott reports positive results from study on its atrial fibrillation therapies 1 day ago Atmus Welcomes Heath Sharp to Board of Directors 2 days ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 2 days ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 4 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 4 days ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 1 day ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 1 day ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 1 day ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 1 day ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 1 day ago Abbott reports positive results from study on its atrial fibrillation therapies 1 day ago Atmus Welcomes Heath Sharp to Board of Directors 2 days ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 2 days ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 4 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 4 days ago
ADVERTISEMENT
AlphaGraphs

Tilray posts narrower loss than expected in Q4

Tilray (NASDAQ: TLRY) reported fourth-quarter 2020 financial results after the regular market hours on Wednesday. The cannabis company reported fourth-quarter revenue of $56.6 million, up 21% year-over-year and above the Wall Street projection. Net loss of $0.02 per share was also narrower than what analysts had anticipated. TLRY shares shot up over 7% immediately following […]

February 17, 2021 1 min read

Tilray (NASDAQ: TLRY) reported fourth-quarter 2020 financial results after the regular market hours on Wednesday. The cannabis company reported fourth-quarter revenue of $56.6 million, up 21% year-over-year and above the Wall Street projection. Net loss of $0.02 per share was also narrower than what analysts had anticipated.

TLRY shares shot up over 7% immediately following the announcement. The stock has increased over 85% over the past 12 months.

Tilray Q4 2020 earnings

Looking forward to listening to management / analyst comments on the results? Stay tuned here for Tilray Q4 earnings call transcript

CEO Brendan Kennedy said, “Amid an acceleration of regulatory changes and an increasingly-favorable political environment, our proposed merger with Aphria will position the combined company as a global leader with lowest cost of production, leading brands, a well-developed distribution network, and unique partnerships.” 

Prior performance

  • Tilray Q3 2020 earnings infographic
  • Tilray (TLRY) Q1 2020 earnings, despite minimal impact from COVID-19 loss widens

ADVERTISEMENT
ADVERTISEMENT